Synthesis and Application of (R)-3-Methylpyrrolidine-3-Carboylic Acid by Dickerson, Shelby D
The University of Southern Mississippi 
The Aquila Digital Community 
Honors Theses Honors College 
Spring 5-2016 
Synthesis and Application of (R)-3-Methylpyrrolidine-3-Carboylic 
Acid 
Shelby D. Dickerson 
University of Southern Mississippi 
Follow this and additional works at: https://aquila.usm.edu/honors_theses 
 Part of the Organic Chemistry Commons 
Recommended Citation 
Dickerson, Shelby D., "Synthesis and Application of (R)-3-Methylpyrrolidine-3-Carboylic Acid" (2016). 
Honors Theses. 414. 
https://aquila.usm.edu/honors_theses/414 
This Honors College Thesis is brought to you for free and open access by the Honors College at The Aquila Digital 
Community. It has been accepted for inclusion in Honors Theses by an authorized administrator of The Aquila 
Digital Community. For more information, please contact Joshua.Cromwell@usm.edu. 
The University of Southern Mississippi 
 
 
 
 
 
Synthesis and Application of (R)-3-Methylpyrrolidine-3-Carboylic Acid 
 
 
 
by 
 
 
 
Shelby Dickerson 
 
 
 
 
 
A Thesis  
Submitted to the Honors College of  
The University of Southern Mississippi 
in Partial Fulfillment 
of the Requirements for the Degree of  
Bachelor of Science 
in the Department of Chemistry and Biochemistry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
May 2016 
  
 ii 
Approved by 
 
 
 
 
 
 
 
 
 
____________________________________ 
Douglas Masterson, Ph.D., Thesis Advisor 
Associate Professor of Chemistry 
 
 
 
 
 
 
 
 
 
____________________________________ 
Sabine Heinhorst, Ph.D., Chair 
Department of Chemistry and 
Biochemistry 
 
 
 
 
 
 
 
 
 
____________________________________ 
Ellen Weinauer, Ph.D., Dean 
Honors College 
 
 
  
 iii 
Abstract 
 
L-Proline is an amino acid widely used in pharmaceutical and biotechnological 
research due to its catalytic activity and biological relevance. L-Proline has been 
recognized and utilized as an organocatalyst, which allows cleaner, more sustainable 
reactions. However, one issue with L-proline is its low solubility in organic systems, 
limiting its reactivity and efficiency, especially when considering industrial research. 
Two reactions that utilize L-Proline are the Michael and Aldol but require 100 mol% of 
L-Proline and 30 mol% of L-Proline, respectively. This research will focus on the 
synthesis of an analogue of L-Proline utilizing inexpensive, commercially available 
reagents. A variety of organic reactions are used to generate the analogue whose structure 
is adapted for better solubility. The analogue is known to the Masterson research group 
and involves a multi-step synthesis, so efforts to improve the current synthetic strategy 
were made to maximize the efficiency of the production for the analogue. The current 
method has shown to be the most efficient pathway allowing maximum production at 
each step. Future goals for the project will include using organic reactions, including 
Aldol and Michael, to analyze the solubility and reactivity of the analogue and compare 
with studies performed with L-Proline.  
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CHAPTER 1: Introduction 
A catalyst decreases the activation energy to allow reactions to occur at faster 
rates. There are numerous reactions that take days or weeks to go to completion; in the 
presence of a catalyst, these times can be dramatically reduced. Catalysts can be seen in 
organisms to aid in biological processes or to increase the efficiency of industrial 
research. There are a variety of catalysts used in chemistry, such as organocatalysts, 
organometallic catalysts, and enzyme catalysts. However, there are benefits to using 
specific catalysts for certain reactions.  
Organocatalysts have contributed to advancements in sustainable chemistry. The 
availability of organocatalysts from natural molecules or variations of natural molecules 
is a major benefit, allowing the production of organocatalysts to be relatively 
inexpensive. Since the catalysts are chiral, there are different enantiomers of the catalysts 
that can exist. Enantiomers are chiral molecules with the same molecular composition 
and are mirror images of each other; however, enantiomers cannot be overlapped 
perfectly, or are not superimposable. Peoples’ feet and hands are examples of chiral 
objects. Despite being mirror images, a person’s hands cannot be overlapped where the 
thumbs perfectly align facing the same direction. 
Enzyme catalysts do not readily make both enantiomers. This is desirable because 
the production of both enantiomers in equal yield, a racemic mixture, is not very useful if 
one enantiomer cannot be extracted from the other. Also, the amount of product yielded 
is reduced because starting material is being used to create the second enantiomer. 
However, the possible applications for enzyme catalysts are lowered because both 
enantiomers are not simultaneously available. Unlike organometallic catalysis, the 
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absence of transition metals in organocatalysts prevents the production of hazardous 
heavy metal waste and allows “cleaner” synthetic reactions. 
The “cleaner” reactions reduce the amount of heavy metal pollution that can result 
from using organometallic catalysts. This is very beneficial for pharmaceutical 
companies because the amount of heavy metals in medications is also reduced. The 
availability of both enantiomers is very helpful in producing different drugs. Each 
enantiomer could have different biological properties, which allows a drug to have 
multiple uses depending on the enantiomer.  
One organocatalyst that is widely used in pharmaceutical research is L-Proline. L-
Proline can be found in cartilage and helps the preservation of heart muscles. It is used in 
a variety of chemical reactions, especially the Aldol, Mannich, and Michael reactions 
because L-Proline is capable of allowing the production of one enantiomer over the other 
in these reactions, which is known as stereoselectivity. The stereoselectivity of L-Proline 
makes it a popular catalyst. However, L-Proline is not very soluble in organic solvents. 
Due to the low solubility, large amounts of the catalyst are then needed for the reactions, 
which is inefficient. One solution to this problem is to generate analogues of L-Proline 
that have better solubility. 
Figure 1a: Comparison of L-Proline and Analogue  
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This research will focus on the application of an analogue of L-Proline, (R)-3-
Methylpyrrolidine-3-Carboxylic Acid (Figure 1). There are a few structural differences 
between L-Proline and the analogue. The main difference between the two catalysts is the 
stereochemistry (L-Proline is S, and the analogue is R). There is also a methyl group on 
the chiral carbon, which is expected to improve the solubility. The amine group is farther 
away from the chiral center, but this is due to the experimental design used to generate 
the analogue. Specifically, the solubility and reactivity of (R)-3-Methylpyrrolidine-3-
Carboxylic Acid will be analyzed using different organic reactions, including the Michael 
and Aldol reactions seen in Scheme 1a and Scheme 2a. 
Once the solubility of the catalyst has been determined, the selectivity of the reaction will 
be studied by analyzing the enantiomeric excess of the enantiomers. This data will then 
be compared to L-Proline to determine if (R)-3-Methylpyrrolidine-3-Carboxylic Acid is a 
more efficient catalyst. 
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CHAPTER 2: Literature Review 
Chiral molecules have major advantages in the pharmaceutical industry. Due to 
the production of enantiomers, the possibilities for biological applications are increased. 
Enantiomers have the potential to behave differently due to the spatial arrangement of the 
functional groups. Because the configurations of two enantiomers are different, the 
interaction of one enantiomer with a drug can differ from the interaction of the second 
enantiomer with the same drug. Previously, artificial drugs were not chiral, but the 
majority of drugs developed from natural sources were chiral1. 
L-Proline is a popular organocatalyst that is naturally abundant in both of its 
enantiomer forms. Because it exists in nature, proline is an inexpensive chiral molecule. 
The two functional groups on proline, the carboxylic acid and the amine group (Figure 
1), allow the catalyst to act as both an acid and a base. This versatility allows proline to 
participate in a variety of reactions. The key feature to proline is its ability to catalyze 
reactions to produce stereoselective molecules. If two enantiomers had opposing 
functionalities but were produced simultaneously in equivalent ratios (racemic mixture), 
then the reaction would be less efficient if only one functionality was needed. Therefore, 
stereoselective reactions allow one enantiomer to be produced in excess, maximizing the 
efficiency of the reaction2. 
The Michael reaction has primarily been studied using enamines with nitro 
olefins, but enamine catalysis has not been as thoroughly explored. Proline is a starting 
point for the enamine catalysis using asymmetric Michael reactions (Scheme 1). A recent 
study used proline in DMSO and methanol solvent systems for ketones and nitro-olefins, 
which can be seen in Scheme 1.  
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Scheme 1b: Example of Michael Reaction 
 
The study produced yields as high as 96%. These reactions did not require harsh 
conditions such as high/low temperatures, inert atmospheres, or metallic salts. However, 
the key issues in these experiments were the low enantioselectivities and high reaction 
times. The highest enantioselective excess reported was 37% when R = CO2Et (ethyl 
ester), R1 = Me (methyl group), and R2 = Et (ethyl group). This set of conditions also 
gave the 96% yield. Since this process has not been thoroughly studied, (R)-3-
Methylpyrrolidine-3-Carboxylic Acid will be used to try and improve the 
enantioselectivity of the Michael reaction products.3 
Another issue with L-proline is its solubility in organic solvent systems, although 
it is very soluble in aqueous systems. The catalyst has been used in Aldol reactions to 
generate carbon-carbon bonds, but the low solubility of proline in organic systems, 50 
mol% of L-Proline in methylene chloride, causes low product yields.4  
Figure 1b: Comparison of Unsubstituted and Substituted Catalysts 
       
Unsubstituted Catalyst          Substituted Catalyst 
This study also required large amounts of the catalyst to be used, which is not very 
efficient. One way the study improved the results was by substituting a methyl group on 
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the chiral carbon on the catalyst, which is seen in Figure 2. This improved the solubility 
in nonpolar organic solvents. The substituted analogue allowed good product yields with 
increases in enantioselectivity compared to the unsubstituted catalyst. By placing 
substituents on the analogues of L-proline, it is possible the solubility of the catalyst can 
be increased in not only the Mannich reaction but other reactions as well, including the 
Michael reaction (Kazuhiro, et. al). The objectives of my research are to synthesize the 
analogue (R)-3-Methylpyrrolidine-3-Carboxylic Acid of L-Proline and test its catalytic 
activity in the Michael reaction5  
 
CHAPTER 3: Methodology  
Catalyst Production: 
Before (R)-3-Methylpyrrolidine-3-Carboxylic Acid can be tested in the Michael 
reaction, the catalyst must be synthesized. The synthetic route developed by the 
Masterson research group at the University of Southern Mississippi will be used as a 
reference in making the catalyst, however the main goal in this project was to optimize 
the reaction conditions to provide the most efficient and inexpensive reaction pathway. 
The synthesis begins with diethyl methylmalonate. This malonate is chosen 
because one of the goals is to have a methyl group substituted on the catalyst. Therefore, 
substituted diesters have been used for the starting point. This malonate undergoes an SN2 
reaction. In this SN2 process, the acidic hydrogen between the two ester groups is 
removed by sodium hydride (NaH) to generate an enolate and hydrogen gas (H2) seen in 
Scheme 2.   
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Scheme 3a: Generation of Enolate  
 
The enolate then attacks one of the carbons on the dibromoethane while bromine leaves 
simultaneously. In this reaction (Scheme 3), a 1:2 molar relationship between the 
nucleophile (enolate) and dibromoethane is usually utilized. However, a purification step 
is needed to remove excess starting material. Therefore, a 1:1 molar ratio will be used in 
this research to try and eliminate the purification step. Other reaction conditions 
including the solvent system and refluxing (addition of heat) will also be manipulated to 
optimize the reaction. 
Scheme 3b: Substitution of Diethyl Methylmalonate 
 
Formation of sodium bromide (NaBr) is an indication that the reaction occurred.  
 The second step of the synthesis is the Gabriel Synthesis (Scheme 4), which is 
also an SN2 reaction. This takes the previous product to react with potassium phthalimide.  
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Scheme 4a: Gabriel Synthesis 
 
Again, formation of the salt potassium bromide (KBr) could indicate the reaction 
occurred, but NMR spectroscopy will be used to confirm the reaction took place. This 
step introduces the nitrogen necessary for the amine seen in the catalyst.  
 In the third step the chiral center of the catalyst is formed with the formation of a 
carboxylic acid from one of the esters. This is a hydrolysis reaction (Scheme 5) with Pig 
Liver Esterase (PLE) in a pH 7.4 buffer.  
Scheme 5a: PLE Hydrolysis 
 
Once the chiral center is generated, para-nitrobenzyl bromide is substituted for 
the hydrogen on the carboxylic acid. This step will help direct cyclization to form the 
pyrrolidinone ring. The addition of para-nitrobenzyl bromide is also a director for the S 
stereochemistry (Scheme 6). This is a novel reaction designed by the Masterson Research 
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Group. Multiple groups can be substituted on the benzene ring, and these groups will also 
affect the stereochemistry of the catalyst.  
Scheme 6a: Addition of Para-Nitrobenzyl Bromide  
 
Once the benzene is added, the cyclization step can occur to form the pyrrolidinone ring 
seen in Scheme 7. Depending on how the cyclization occurs, the R or S enantiomer can 
be produced. If cyclization occurs on the side with the benzene, the S enantiomer is 
produced (Scheme 7). If cyclization occurs on the side with the ester group, the R 
enantiomer is produced (Scheme 7). This selective step is novel in the Masterson 
research lab and a variety of functional groups were used to test selectivity.67 Using para-
nitrobenzyl bromide, as seen in Scheme 7, allowed a 78:1 molar ratio of S:R.  
Scheme 7a: Selective Cyclization 
 
 After cyclization, a phenyl group will be added to the compound using benzyl 
bromide (Scheme 8). Again, this is an SN2 reaction using sodium hydride to generate the 
nucleophile from starting material.  
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Scheme 8a: Addition of Benzyl Group to Nitrogen 
 
 
 
Scheme 9: Formation of Thioketones 
 
Once the thioketone is formed, it can be removed using Raney-nickel catalyst in Scheme 
108910.  
Scheme 10: Removal of Thioketones 
 
Lithium hydroxide (LiOH) will be used to convert the remaining ester group to a 
carboxylic acid group, generating the same product from the two reactants (Scheme 11).  
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Scheme 11: Generating Carboxylic Acid 
 
 The final step is the removal of the benzene group seen in Scheme 12. This will 
be done using hydrogen and palladium catalyst.  
Scheme 12: Formation of Target Catalyst 
 
Once the benzyl group is removed, the synthesis of the catalyst is complete. Because this 
reaction is known in the Masterson laboratory, optimization of the synthesis will be a 
potential goal for certain steps. The complete synthetic route is displayed in Scheme 13.11 
Once enough of the catalyst is generated, it can be tested in the Michael reaction.  
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Scheme 13: Complete Synthesis of (R)-3-Methylpyrrolidine-3-Carboxylic Acid 
 
 
 
 
Experimental Procedure: 
The protocol utilized in this studied was based on the synthetic route developed by Dr. 
Banerjee and the Masterson Research Group.  
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General Methods: 
“THF, CH2Cl2, and DMF were dried by passage through activated alumina. All reagents 
were used as received unless otherwise stated. Flash chromatography was performed 
using P-60 silica gel, and TLC analysis was performed using silica precoated TLC plates. 
Pig liver esterase (PLE) refers to the commercially available crude preparation12.”  
 
Synthesis of Diethyl 2-(2-Bromoethyl)-2-methylmalonate (1): 
Approximately 65 mL of dry THF was added to 2.35 g of NaH (58.5 mmol, 60% 
suspension in mineral oil) under N2 atmosphere before being cooled to 0C. A solution of 
10.2 g of diethyl-2-methylmalonate (58.6 mmol) in THF was added over 20 minutes, 
with stirring at rt. A solution of 10.9 g dibromoethane (58.0 mmol) in THF was added 
dropwise with stirring under N2 atmosphere. The reaction mixture refluxed overnight. 
Half the solvent was evaporated under reduced pressure, and the solution was diluted 
with a 5% solution of HCl and water. The mixture was washed with CHCl3 (3 X 30 mL), 
washed with brine, dried over MgSO4, and filtered. The remaining solvent was 
evaporated under reduced pressure. The resulting yellow liquid was distilled to remove 
the excess dibromoethane, diethyl-2-methylmalonate, and THF giving 9.0 g (29 mmol, 
47%) of 1 as a yellow liquid. 1H NMR corresponded to literature. 
 
Synthesis of Diethyl 2-Methyl-2-[2-(1,3-dioxoisoidndolin-2-yl)ethyl)malonate (2): 
Approximately 6.8 g of 1 (22.4 mmol) was placed in a 250 mL sealed tube with 120 mL 
DMF. A 5.3 g (28.6 mmol) portion of potassium phthalimide was added to the sealed 
tube. The reaction mixture stirred at 90C overnight. The reaction mixture was cooled to 
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rt, diluted with 300 mL of H2O, and extracted with Et2O (3 X 200 mL). The combined 
organic layer was washed with water (10 X 100 mL), washed with brine (2 X 100 mL), 
dried over MgSO4, filtered, and evaporated under reduced pressure giving the crude 
product was a white solid. The crude was recrystallized from cold Et2O giving 1.62 g (4.4 
mmol, 23%) of 2 was a white solid. 1H NMR corresponded to literature. 
 
Synthesis of (R)-2-(N-Ethylphthalimido)-3-ethoxy-2-methyl-3-oxopropanoic Acid (3): 
A 6.5 g portion of 2 (17.6 mmol) was add to 610 mL of phosphate buffer (0.1 N, pH 7.4) 
with stirring. An 89.3 mg portion of pig liver esterase (PLE) (27 units/mg, 90 unites per 
mmol of the substrate) was added to the buffer. The pH was maintained with an auto 
buret set to deliver 1 equivalent of 1 N NaOH solution to keep a pH of 7.4. The 
hydrolysis proceeded overnight. The pH was lowered to 1 with concentrated HCl and 
extracted three times with 600 mL of Et2O. The combined organic layer was dried over 
MgSO4, filtered, and concentrated under reduced pressure giving 1.87 g (5.5 mmol, 31%) 
crude product as yellow viscous oil. 1H NMR corresponded to literature. 
 
Synthesis of (S)-1-(4-Nitrobenzyl)-3-ethyl-2-methyl-[2-(1,3-dioxoisoindolin-
2yl)ethyl]malonate (4): 
A portion of 0.76 g of K2CO3 (5.5 mmol) was added to a solution of 1.87 g of 3 (5.5 
mmol) in 20 mL of DMF. Approximately 1.1 g (5.1 mmol) of para-nitrobenzyl bromide 
was slowly added to the solution. The reaction stirred overnight under an N2 atmosphere. 
The reaction mixture was then diluted with 20 mL of water and washed with Et2O (3 X 
20 mL). The combined organic layer was washed with water (5 X 20 mL), washed with 
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brine (2 X 20 mL), and dried over MgSO4. The solvent was removed under reduced 
pressure, and 1.79 g (3.8 mmol, 76%) of 4 was obtained as a white solid. 1H NMR 
corresponded to literature. 
 
Synthesis of (R)-Ethyl 3-Methyl-2-oxopyrrolidine-3-carboxylate (5): 
Approximately 400 microliters (4.1 mmol) of 35% hydrazine in water was added to 1.69 
g (3.5 mmol) 4 in solution with 24 mL of MeOH. The reaction mixture was refluxed 
overnight, resulting in the formation of white precipitate. The solution was cooled to rt 
and filtered. The solvent was removed from the filtrate under reduced pressure to obtain a 
solid, which was put back into solution with CH2Cl2. The solution was washed with H2O 
(1 X 100 mL), and the organic layer was dried with MgSO4, filtered, and placed under 
reduced pressure. The resulting solid was “chromatographed using 30% hexanes/EtOAc” 
producing 0.2 g (0.8 mmol, 25%) of 5 as pure white solid. 1H NMR corresponded to 
literature. 
 
Synthesis of (R)-Ethyl 1-Benzyl-3-methyl-2-oxopyrrolidine-3-carboxylate (6): 
A volume of 2 mL anhydrous THF was added to 0.4 g (1.8 mmol) of 5. The solution was 
slowly added to 0.07 g NaH (2.9 mmol) in (volume) of THF at 0C under a N2 
atmosphere and stirred for 5 minutes. Approximately 0.3 g of BnBr (1.8 mmol) was 
added dropwise, and the mixture stirred for 10 minutes at C. The reaction was warmed 
to rt and continued for 1 hour at rt. Dry DMF 10 mL was added to the reaction and 
continued stirring for 2 h. The mixture was added to 7 mL of H2O where the water layer 
was extracted with Et2O (3 X 20 mL). The combined organic layer was washed with 
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water (5 X 20 mL) and dried over MgSO4. The solvent was removed under reduced 
pressure, and the resulting oil was “chromatographed (gradient, 15-20% 
EtOAc/hexanes)” allowing 0.14 g (0.5 mmol, 19%) of 6.  1H NMR corresponded to 
literature. 
 
Michael and Aldol Reactions: 
To test the reactivity of the analogue, a series of trials will be conducted for the 
Michael and Aldol reactions. These will include different solvent systems, protic and 
aprotic, to see if better enantioselectivity is seen compared to the literature values of L-
proline. Potential reactions for the study are displayed in Schemes 14a-b, but the 
analogue will be used in place of (S)-proline.  
 
Scheme 14a:  Michael Reaction  
 
Scheme 14b: Aldol Reaction 
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Once each of the reactions has been conducted, the enantioselectivity of each experiment 
will be compared to the literature values of the (S)-proline reactions.  
CHAPTER 4: Results 
Synthesis of Catalyst 
Scheme 3c: Alkylation of Diethyl Methylmalonate 
 
Trial 
Molar Ratio of 
Diethyl 
Methylmalonate 
to 
Dibromoethane 
Solvent Reflux 
Amount of 
Diethyl 
Methylmalonate 
Used 
Percent 
Yield 
1 1:1 DMF No 5 mL 51.57 
2 1:1 THF No 10 mL 55.11 
3 1:1 THF Yes 10 mL 10.10 
4 1:1 THF Yes 40.81 g 87.96 
5 1:1 THF Yes 40.80 g 16.57 
6 1:1 THF Yes 20 mL 9.60 
7 1:1 THF Yes 20 g 47.24 
Table 1 displays different trials for the alkylation of diethyl methylmalonate using 
different reaction conditions with yields. The table specifies the solvent used, quantity of 
diethyl methylmalonate used, and whether or not the solution was refluxed. 
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Figure 2 depicts the NMR for the alkylation product. The peaks and values correspond to 
Dr. Banerjee’s reported spectrum.  
Scheme 4b: Gabriel Synthesis 
 
Trial 
Amount of Starting 
Material Used 
Percent Yield 
1 10.91 g 9.79 
2 6.76 g 22.90 
3 16.63 g 36.15 
Table 2 shows the amount of starting material used for each trial in the Gabriel Synthesis 
and the corresponding percent yield.  
O O
O O
Br
A
AA
BB
B
C
C
D
D
E
E
 19 
 
Figure 3 depicts the NMR for the substituted product. The peaks and values correspond 
to Dr. Banerjee’s reported spectrum. 
Scheme 5b: PLE Hydrolysis 
 
Trial 
Amount of Starting 
Material Used 
Percent Yield 
1 1.32 g 55.23 
2 6.74 21.57 
3 6.80 g 24.94 
4 6.50 g 31.13 
Table 3 shows the amount of starting material used for each trial in the PLE Hydrolysis 
and the corresponding percent yield. 
O O
O O
N
O
O
A
A
A
A
A
B
B
C
C
D
D
E
EE
F
FF
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Figure 4 depicts the NMR for the chiral product. The peaks and values correspond to Dr. 
Banerjee’s reported spectrum. 
 
Scheme 6b: Substitution of Para-Nitrobenzyl Bromide 
 
Trial 
Amount of Starting 
Material Used 
Percent Yield 
1 2.05 g 38.33 
2 1.87 g 76.20 
Table 4 shows the amount of starting material used for each trial in the reaction and the 
corresponding percent yield. 
O OH
O O
N
O
O
A
A
AA
A
B
B
C
CD
D
E
E
F
F
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Figure 5 depicts the NMR for the substituted product. The peaks and values correspond 
to Dr. Banerjee’s reported spectrum. 
Scheme 7b: Selective Cyclization 
 
Trial 
Amount of Starting 
Material Used 
Percent Yield 
1 1.69 g 38.33 
Table 5 shows the amount of starting material used in the cyclization step and the 
corresponding percent yield. 
O O
O O
N
O
O
NO2
A
AB B
C
C
D
D
E
E
F
G
H
F
G
H
A
A
A
B
B
B
B
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Figure 6 depicts the NMR for the cyclized product. The peaks and values correspond to 
Dr. Banerjee’s reported spectrum. 
 
Scheme 8b: Addition of Benzyl Groups 
 
Trial 
Amount of Starting 
Material Used 
Percent Yield 
1 0.4435 g 27.72 
Table 6 shows the amount of starting material used in the addition and the corresponding 
percent yield. 
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Figure 7 depicts the NMR for the benzyl-substituted products. The peaks and values 
correspond to Dr. Banerjee’s reported spectrum. 
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Scheme 15: Steps Completed in Synthesis 
 
 
 
CHAPTER 5: Discussion 
Looking at the individual steps in the synthesis, one can conclude the current 
synthetic pathway is most optimized for this analogue. When considering the first step, 
the goal was to reduce the need for purification. The protocol for purification involved 
distillation, which is a time-consuming process, and the presence of starting material 
indicated the reaction was not going to completion. Changing the molar ratio of diethyl 
methylmalonate to dibromoethane to 1:1 was a proposed solution because it would 
decrease the amount of starting material leftover from the reaction. However, purification 
was still needed with this molar ratio as seen in the NMR (Figure 3). A peak around 1.5 
ppm that integrates to 1.39 signifies the presence of unreacted diethyl methylmalonate. 
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Also, the reaction yields (Table 1) were half the yield reported with the 2:1 molar ratio. 
Trial 4 has a high percent yield but it is believed to be due to a tear mass error.  Changing 
the solvent system and reflux conditions did not really change this outcome. Another 
issue with early trials was deciding which reactant was in excess. The procedure said to 
add the generated enolate to dibromoethane, but errors in technique had the 
dibromoethane being added to the enolate. This could have affected the rate of the 
reaction and prohibited the reaction from reaching completion. However, low yields were 
still being seen when the generated enolate was added to dibromoethane. Therefore, it 
was decided the current synthetic pathway with the 2:1 molar ratio provided the most 
optimized and efficient reaction conditions.   
Once enough alkylated diester was produced, the next reaction was the Gabriel 
Synthesis, which replaced the bromide with a phthalimide group. This step does not have 
an extensive purification process like the previous because the product crystallizes pure 
out of solution after work up. The first few trials have low yields (Table 2), and the NMR 
(Figure 3) is pure for the crude product except for some remaining phthalimide but not 
enough to cause concern.  
The following step was the addition of para-nitrobenzyl bromide. Trial 1 showed 
a low yield but required purification by column. Column purification is very tedious and 
loss of mass can be an issue, especially if beginning with low mass. Therefore, the low 
yield could be contributed to having a small scale (2.05 g starting material). Also, this 
reaction must be stopped after a certain amount of time or the desired product will start 
reacting again. Therefore, it is possible not all of the para-nitrobenzyl bromide was added 
in the reaction. Trial 2, however, shows improvement in yield with no purification 
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needed, so technique could also have contributed to the low yield in Trial 1. NMR 
analysis (Figure 5) showed purified material after purification for Trial 1.  
The cyclization of the phthalimide group had a low yield (38.33%), but the 
reported yield was 40%. Therefore, despite the “low” yield, the reaction went very well 
because it is known to be a low-yielding step. Column purification was also utilized in 
this step but not much mass loss was seen. After purification, NMR (Figure 6) showed 
purified product. This reaction also had a small scale due to the low yield in the para-
nitrobenzyl bromide substitution reaction, so lack of material was staring to become a 
concern when this step produced less than a gram of material. 
After cyclization, benzyl groups were added to the amine and ester groups as 
demonstrated in Scheme 8, which actually give two products. NMR analysis confirmed 
the production of both products (Figure 7), which complicates the spectra, but peaks at 
2.5 ppm and 3.25 ppm confirm the diasteric hydrogens. As seen in Scheme 13, having 
two products is not a concern because both will lead to the catalyst in the synthetic route. 
This step also had a low yield, but column purification was also needed after working up 
the reaction. Therefore, loss of mass could have also resulted from running a column, 
especially since less than a gram of material was used for starting material.  
Limitations  
The synthesis of the catalyst (R)-3-Methylpyrrolidine-3-Carboxylic Acid was not 
completed. This was due to a variety of factors relevant to specific steps in the synthesis. 
Specifically, lack of material prevented the advancement of synthesis, and time had to be 
taken to build up starting material at various points during the project.  
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The first step in the synthesis, the alkylation of diethyl methylmalonate, took the 
longest since attempts at optimization were taken. The original synthetic strategy calls for 
a 1:2 molar ratio of diethyl methylmalonate to dibromoethane. However, purification was 
needed in this step due to the presence of starting material. In this project, one of the 
goals was to manipulate the reaction conditions to minimize the amount of starting 
material leftover from the reaction. Therefore, a 1:1 molar ratio of diethyl 
methylmalonate to dibromoethane was suggested as an initial change. Table 1 shows 
differences in other conditions such as solvent, reflux, and scale size of each optimization 
trial. The percent yield for each trial was also measured for comparison to the yield of 
original reaction conditions. Due to the low yields observed, more time was taken to 
generate enough material to continue the synthesis.  
During the PLE hydrolysis step, there were some issues with electrodes of the 
titrator that influenced the reaction. During the titration, a set amount of base was 
expected to be added but only half of that amount was being added during Trials 2-3. 
During calibration of the electrodes, the electrodes were not stabilizing. This limited the 
production of the chiral product and lowered the yield of this reaction.  
For several of the reactions, column chromatography was used for purification. 
This is a very tedious, time-consuming process. Columns were more relevant towards the 
end of the synthetic route when material was low, so extra care was given while running 
columns to insure all products were removed from the columns for maximum yields; 
however, loss of mass is a possibility when using columns.  
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CHAPTER 6: Conclusions 
This study suggests the established synthetic pathway is the most optimized for 
the desired analogue (R)-3-methylpyrolidine carboxylic acid. The reaction yields above 
are significantly lower than those reported by the Masterson Research Group, so the 
focus of the research shifted to completing the synthesis of the analogue instead of 
optimization. Once the analogue is produced, its solubility and catalytic reactivity will be 
tested and compared with L-proline’s.  
Future Research 
Future goals of the project include completing the synthesis of the catalyst. 
Because the last successful step was the addition of para-nitrobenzylbromide, the 
remaining steps include Lawesson’s, Raney-Ni, acid/base, and catalytic hydrogenation 
reactions. Once the catalyst is synthesized, enough must be generated for catalytic studies 
of Michael and Aldol reactions. The solubility of the catalyst and stereoselectivity of the 
reactions will be observed and compared to literature data on reactions with L-proline.   
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